223 related articles for article (PubMed ID: 11859869)
1. Phenylketonuria and glycogen storage disease type III in sibs of one family.
Yilmazer T; van Gennip AH; Abeling NG; Ozalp I; Coşkun T; Bakker HD
Turk J Pediatr; 2002; 44(1):49-53. PubMed ID: 11859869
[TBL] [Abstract][Full Text] [Related]
2. A nonsense mutation due to a single base insertion in the 3'-coding region of glycogen debranching enzyme gene associated with a severe phenotype in a patient with glycogen storage disease type IIIa.
Shen J; Bao Y; Chen YT
Hum Mutat; 1997; 9(1):37-40. PubMed ID: 8990006
[TBL] [Abstract][Full Text] [Related]
3. Glycogen storage disease: clinical, biochemical, and molecular heterogeneity.
Shin YS
Semin Pediatr Neurol; 2006 Jun; 13(2):115-20. PubMed ID: 17027861
[TBL] [Abstract][Full Text] [Related]
4. Debrancher enzyme activity in blood cells of families with type III glycogen storage disease. A method for diagnosis of heterozygotes.
Chayoth R; Moses SW; Steinitz K
Isr J Med Sci; 1967; 3(3):422-6. PubMed ID: 5317552
[No Abstract] [Full Text] [Related]
5. A single-base deletion in the 3'-coding region of glycogen-debranching enzyme is prevalent in glycogen storage disease type IIIA in a population of North African Jewish patients.
Parvari R; Moses S; Shen J; Hershkovitz E; Lerner A; Chen YT
Eur J Hum Genet; 1997; 5(5):266-70. PubMed ID: 9412782
[TBL] [Abstract][Full Text] [Related]
6. Clinical and genetic variability of glycogen storage disease type IIIa: seven novel AGL gene mutations in the Mediterranean area.
Lucchiari S; Fogh I; Prelle A; Parini R; Bresolin N; Melis D; Fiori L; Scarlato G; Comi GP
Am J Med Genet; 2002 May; 109(3):183-90. PubMed ID: 11977176
[TBL] [Abstract][Full Text] [Related]
7. Glycogen storage diseases.
Hug G
Birth Defects Orig Artic Ser; 1976; 12(6):145-75. PubMed ID: 788807
[TBL] [Abstract][Full Text] [Related]
8. [Debranching enzyme activity in leukocytes and glycogen content of erythrocytes in patients with type III glycogenosis].
Pieniazek D; Pronicka E; Miłoszewska E; Maciejko D; Gruszczyńska B
Pediatr Pol; 1983 May; 58(5):447-53. PubMed ID: 6226925
[No Abstract] [Full Text] [Related]
9. Glycogen storage disease type IIIa: first report of a causative missense mutation (G1448R) of the glycogen debranching enzyme gene found in a homozygous patient.
Okubo M; Kanda F; Horinishi A; Takahashi K; Okuda S; Chihara K; Murase T
Hum Mutat; 1999 Dec; 14(6):542-3. PubMed ID: 10571954
[TBL] [Abstract][Full Text] [Related]
10. Molecular characterisation of GSD III subjects and identification of six novel mutations in AGL.
Lucchiari S; Donati MA; Parini R; Melis D; Gatti R; Bresolin N; Scarlato G; Comi GP
Hum Mutat; 2002 Dec; 20(6):480. PubMed ID: 12442284
[TBL] [Abstract][Full Text] [Related]
11. A new variant form of phenylketonuria.
Watts RW; Purkiss P; Chalmers RA
Q J Med; 1979 Jul; 48(191):403-17. PubMed ID: 317358
[TBL] [Abstract][Full Text] [Related]
12. Bulbar muscle weakness and fatty lingual infiltration in glycogen storage disorder type IIIa.
Horvath JJ; Austin SL; Jones HN; Drake EJ; Case LE; Soher BJ; Bashir MR; Kishnani PS
Mol Genet Metab; 2012 Nov; 107(3):496-500. PubMed ID: 23062577
[TBL] [Abstract][Full Text] [Related]
13. [Genetic heterogeneity and the diagnosis of hepatic glycogenoses].
Lemonnier A; Baussan C; Moatti N
C R Seances Soc Biol Fil; 1984; 178(4):327-47. PubMed ID: 6241011
[TBL] [Abstract][Full Text] [Related]
14. [Diagnosis of glycogen storage disease type IIIA by detecting glycogen debranching enzyme activity, glycogen content and structure in muscle].
Wang W; We M; Song HM; Qiu ZQ; Zhang WM; Wu XY; Lu CX; Qi JM; Jing H; Li F
Zhonghua Er Ke Za Zhi; 2009 Aug; 47(8):608-12. PubMed ID: 19951495
[TBL] [Abstract][Full Text] [Related]
15. Glycogen storage disease type IX: High variability in clinical phenotype.
Beauchamp NJ; Dalton A; Ramaswami U; Niinikoski H; Mention K; Kenny P; Kolho KL; Raiman J; Walter J; Treacy E; Tanner S; Sharrard M
Mol Genet Metab; 2007; 92(1-2):88-99. PubMed ID: 17689125
[TBL] [Abstract][Full Text] [Related]
16. Molecular genetic basis and prevalence of glycogen storage disease type IIIA in the Faroe Islands.
Santer R; Kinner M; Steuerwald U; Kjaergaard S; Skovby F; Simonsen H; Shaiu WL; Chen YT; Schneppenheim R; Schaub J
Eur J Hum Genet; 2001 May; 9(5):388-91. PubMed ID: 11378828
[TBL] [Abstract][Full Text] [Related]
17. Mutational and haplotype analysis of AGL in patients with glycogen storage disease type III.
Horinishi A; Okubo M; Tang NL; Hui J; To KF; Mabuchi T; Okada T; Mabuchi H; Murase T
J Hum Genet; 2002; 47(2):55-9. PubMed ID: 11924557
[TBL] [Abstract][Full Text] [Related]
18. Mutational analysis of the AGL gene: five novel mutations in GSD III patients.
Lucchiari S; Donati MA; Melis D; Filocamo M; Parini R; Bresolin N; Comi GP
Hum Mutat; 2003 Oct; 22(4):337. PubMed ID: 12955720
[TBL] [Abstract][Full Text] [Related]
19. [Nine cases of debrancher deficiency (glycogen storage disease type III) presenting muscle weakness--study on clinicobiochemical analysis].
Fukuda T; Sugie H; Ito M; Tsurui S; Sugie Y; Igarashi Y
Rinsho Shinkeigaku; 1996 Apr; 36(4):540-3. PubMed ID: 8810846
[TBL] [Abstract][Full Text] [Related]
20. Tetrahydrobiopterin protects phenylalanine hydroxylase activity in vivo: implications for tetrahydrobiopterin-responsive hyperphenylalaninemia.
Thöny B; Ding Z; Martínez A
FEBS Lett; 2004 Nov; 577(3):507-11. PubMed ID: 15556637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
